Reproductive health disorders significantly impact individuals worldwide, covering a broad spectrum of conditions that can harm the reproductive system, potentially leading to infertility or complications during childbirth. These disorders include menstrual disorders, polycystic ovary syndrome, sexually transmitted infections (STIs), reproductive tract infections, prostate disorders, and testicular disorders.

Common STIs include both curable (gonorrhea, chlamydia, syphilis, trichomoniasis) and treatable (herpes viruses, human papillomavirus, human immunodeficiency virus) conditions. Previously referred to as sexually transmitted diseases (STDs), STIs can present with a range of symptoms or remain asymptomatic, making it possible for individuals to have an infection without being aware of it. Bacterial STIs, such as chlamydia, gonorrhea, and syphilis, can be treated and cured with antibiotics. Conversely, viral STIs, including hepatitis, herpes, HIV, and HPV, can be managed with treatment but cannot be completely cured. Early and accurate detection of these conditions is paramount for effective treatment and symptom management.

G2M offers a broad range of CE-IVD approved RT-PCR IVD kits with high sensitivity and specificity, enabling accurate identification of reproductive health diseases. These RT-PCR kits are extensively compatible with commonly available real-time PCR instruments, exhibit no cross-reactivity with other pathogens, and ensure timely and accurate detection, which is crucial for the effective treatment and management of reproductive health disorders.

G2M Provides two advanced diagnostic tools that ensure precision and reliability in the detection of multiple pathogens responsible for Sexually Transmitted Infections

STI-Q Comprehensive Real-Time PCR Kit offers a sophisticated solution for the qualitative detection and differentiation of 13 organisms associated with sexually transmitted infections. This innovative multiplex kit not only enables accurate diagnosis but also incorporates a parallel detection of an internal control, enhancing the reliability of results. The pathogens identified by the STI-Q comprehensive kit include:

STI7-Q Real-Time PCR Kit is specifically engineered to qualitatively detect and differentiate seven major STI pathogens in clinical samples. The kit features a user-friendly interface that depicts specific amplification plots, providing clear results for Herpes Simplex Virus-1 (FAM channel) alongside an endogenous internal control (Cy5 channel). The pathogens covered include: